- Flagship startup Serif says it has solved non-viral gene therapy in monkeysBOSTON — Serif Biomedicines, a startup launched last month by Flagship Pioneering, believes it has solved two technical challenges that have long prevented gene therapy from being delivered without…Endpoints · 2mo ago↗ source
- Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2BIt's becoming Hengrui Pharma's world, and some Western drugmakers are just living in it. China's largest pharma company, which boasts one of the biggest pipelines in the industry, has lined up Br…Endpoints · 2mo ago↗ source
- <![CDATA[Real-World Data Highlight Survival Benefit of Rituximab Maintenance After Frontline BR in MCL]]><![CDATA[Rituximab following first-line bendamustine demonstrated significant OS and EFS real-world benefits in mantle cell lymphoma.]]>